In conclusion, our results from lung cancer patients, animal models, and in vitro studies indicate that M-CSF-mediated M2-polarized TAMs promote migration of cancer cells, suggesting that M2 macrophages are triggered by Oct4- overexpressing cancer cells and M-CSF may be a therapeutic target for lung cancer. This evidence concerns the gene CSF1 and cancer.